- Home
- CASI vs XOS Comparison
CASI vs XOS Comparison
Compare CASI & XOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CASI | XOS |
|---|---|---|
| Founded | 1991 | 2016 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Construction/Ag Equipment/Trucks |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.9M | 26.3M |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | CASI | XOS |
|---|---|---|
| Price | $0.75 | $2.02 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 1 |
| Target Price | $4.00 | ★ $7.00 |
| AVG Volume (30 Days) | 33.4K | ★ 48.9K |
| Earning Date | 11-14-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $26,846,000.00 | ★ $52,246,000.00 |
| Revenue This Year | N/A | $0.55 |
| Revenue Next Year | N/A | $29.10 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 21.72 | N/A |
| 52 Week Low | $0.80 | $2.00 |
| 52 Week High | $3.47 | $9.15 |
Technical Indicators
Market Signals| Indicator | CASI | XOS |
|---|---|---|
| Relative Strength Index (RSI) | 26.78 | 34.70 |
| Support Level | $0.83 | $2.00 |
| Resistance Level | $0.95 | $2.19 |
| Average True Range (ATR) | 0.09 | 0.14 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 5.95 | 1.82 |
Price Performance
Historical ComparisonAbout CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.
About XOS Xos Inc.
Xos Inc is a fleet electrification solutions provider committed to the decarbonization of commercial transportation. Xos designs and manufactures Classes 5 through 8 battery-electric commercial vehicles that travel on last-mile, back-to-base routes of up to 200 miles per day. Xos also offers charging infrastructure products and services through Xos Energy Solutions to support electric vehicle fleets. Its products include Stepvan, MDXT, HDXT, Xosphere, and Xos Energy Solutions.